Rabiral is indicated for the treatment of:
Active duodenal ulcer
Active benign gastric ulcer
Symptomatic erosive or ulcerative gastro-oesophageal reflux disease
Patients with known hypersensrtivity to Rabeprazole sodium or to one of the components
Pregnancy and lactation
Rabiral tablets were generally well tolerated, but may cause headache, diarrhea, include rhinitis , abdominal pain, vomiting, flatulence, dizziness, dry mouth, and rash.
Dosage and Administration:
a. Active duodenal ulcer and active benign gastric ulcer. The recommended dose for both is 20mg to be taken once daily in the morning.Some patients with active duodenal ulcer may respond to one 1umg tablet to be taken once daily in the morning. Most patients with active duodenal ulcer heal with 2 - 4 weeks.
A few patients may need an additional 4 weeks of therapy to achieve healing.
b. Rabiral is indicated fore the long-term of pathological hyper secretory conditions; including Zollinger-Ellison syndrome.
c. Ulcerative gastro-oesophageal reflux disease . The recommended dose is 20 mg to be taken once daily for 4 - 8 weeks. Rabiral tablets should be taken in the morning before eating and should be swallowed whole.
Boxes of 20 E. ctd tablets.